Insider Trades0 trades
No trades match the current filters
/DRUG
AI Summary
StalkDRUG is in a Stage 4 decline with price below all major EMAs and the 50-DMA. Recent bounce into moving averages has not reclaimed resistance and underscores seller control. Intermediate structure favors further downside, but short-term timing is neutral due to oversold conditions. Selling into EMA and DMA resistance zones remains the preferred approach, with a decisive break above the 21-EMA and 50-DMA on strong volume required to invalidate the bearish thesis.